Baxter (BAX) Tops Q3 EPS by 6c, Revenues Beat; Offers FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018
October 31, 2018 7:15 AM EDTThird-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 3 percent on an operational basis Third-quarter GAAP earnings per share (EPS) of $1.00; Adjusted EPS of $0.80 increased 25 percent Company expects full-year 2018 sales growth of approximately 5 percent on a reported basis and approximately 3 percent on an operational basis Company expects full-year 2018 GAAP EPS of $2.90 to $2.94; Adjusted EPS of $2.98 to $3.00
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today... More
